Clinical Trials Browser

Phase 4 × Uterine Cervical Neoplasms × pegylated granulocyte colony-stimulating factor × Clear all

NCT03206684 2017-08-28

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

Phase 4 Unknown

Uterine Cervical Neoplasms